“deutsche-bank” Archives

Entry Author Date Location
NuuED Obtains $3,000,000 New Round 02/10/16 San Francisco
Can Banks Ride the Surge of Fintech, Or Has the Wave Gotten Too High? 10/23/15 New York
Biopharma CEOs, VCs, and Hedge Fund Managers: Fifty Shades of Greed 10/07/15 National
BioLite Secures $5,000,000 Series B Funding 07/30/15 New York
LexShares, Out of Stealth, Brings Crowdfunding to Litigation Financing 11/26/14 New York
Arrowhead Shares Tumble on Early Phase 2a Data For RNAi Drug 10/09/14 Wisconsin
SnakBlox, Out of Stealth, Measures Social Data for Hearst Digital 10/28/13 New York
OnDeck Garners $130,000,000 New Financing Round 09/16/13 New York
Vimbly Secures $540,000 Seed Financing 05/04/13 New York
Crowdfunding Is Coming to Biotech, so Get Ready for a Wild Ride 01/28/13 National
WaveDivision Aims to Continue Growth With $1B Recapitalization 11/15/12 Seattle
Omeros Pockets $28M in Stock Sale 06/28/12 Seattle
Xconomist of the Week: Roger Ehrenberg Plans for Deeper Investments 04/05/12 New York
New York Entrepreneurs Pitch VCs on “FinTech” Startups 07/25/11 New York
Demandware Files for IPO 07/15/11 Boston
ServiceSource Raises $111M in IPO 03/25/11 San Francisco
Fluidigm Raises $75M in Second Chance at IPO 02/10/11 San Francisco
PacBio Seeks $200M IPO to Gain Edge in Booming DNA Sequencing Market 08/16/10 San Francisco
Fina Technologies Aiming to Build Smarter Computer Models for Wall Street 01/14/10 Boston
Dendreon Seeks to Raise More Than $400 Million to Support Prostate Cancer Drug Launch 12/08/09 Seattle
Omeros Banks on First FDA Filing Next Year, Plans to “Unlock” Inaccessible Drug Targets 11/19/09 Seattle
Dilithium Networks Lands $10,900,000 New Funding Round 10/27/09 San Francisco
Amazon Invests in Engine Yard, PopCap Raises $22.5M, Omeros Goes Public, & More Seattle-Area Deals News 10/14/09 Seattle
Omeros Raises $68.2M in Washington’s First IPO in Two Years 10/08/09 Seattle
Omeros Teed Up for IPO Next Week, Seeking to Rake In More Than $80M 10/02/09 Seattle
Dendreon Tames Short Sellers, Transforms Itself into Old-School Buy-and-Hold Stock 06/30/09 Seattle
Dendreon Drug Works, But Can It Manufacture Enough to Meet Demand? 05/20/09 Seattle
Dendreon Sells Shares To Raise $200M For Provenge Manufacturing, Marketing 05/08/09 Seattle
Qualcomm May Slow Verizon’s LTE Rollout 04/06/09 San Diego
Page 1 of 1